Swift
Principal executive officer pay for Swift, by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
Pediatrix Medical Group, Inc. (MD) FY2023–FY2025
Beat peersTSR 160% vs peer group -22% over FY2023–FY2025
Turnaround$100 invested moved from behind the peer group ($33.47 vs $99.53) to ahead ($87.16 vs $77.88) over FY2023–FY2025
Aligned: paid up as stock roseCAP $1,620,732→$2,954,364 while $100 invested went $33.47→$87.16
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2023 | $2.2M | $1.6M |
| FY2024 | $3.3M | $4.4M |
| FY2025 | $2.8M | $3.0M |
The company's "$100 invested" index ran $33.47 at FY2023 → $87.16 by FY2025 — an annualized return of 61.4%.
Pediatrix Medical Group, Inc. (MD) FY2023–FY2023
Tracked peersTSR $33.47→$33.47 vs peer group $99.53→$99.53 (FY2023–FY2023)
Aligned: pay fell with the stockCAP $1,620,732→$1,620,732 while $100 invested went $33.47→$33.47
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2023 | $2.2M | $1.6M |
The company's "$100 invested" index ran $33.47 at FY2023 → $33.47 by FY2023.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: 61.4%/yr at MD ( FY2023–FY2025). See the CEO track-record ranking for context.
All disclosed tenures: 2 years across 1 companies, $100 → $260.41 combined (61.4%/yr). Chained through each company's own "$100 invested" index, one stint after the next — still bounded by disclosure, which began with fiscal year 2022, not by the full career.